Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.

• Revenue in USD (TTM)1.13bn
• Net income in USD70.20m
• Incorporated2021
• Employees2.20k

• Location
  Embecta Corp300 Kimball Drive, Suite 300PARSIPPANY NJ 07054United StatesUSA
• Phone+1 (862) 401-0000
• Fax+1 (302) 655-5049
• Websitehttps://www.embecta.com/